Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats

被引:25
|
作者
Ikeda, Y
Nakamura, T [1 ]
Takano, H
Kimura, H
Obata, JE
Takeda, S
Hata, A
Shido, K
Mochizuki, S
Yoshida, Y
机构
[1] Yamanashi Med Univ, Div Blood Transfus, Yamanashi 4093898, Japan
[2] Yamanashi Med Univ, Dept Internal Med, Yamanashi 4093898, Japan
[3] Yamanashi Med Univ, Dept Pathol, Yamanashi 4093898, Japan
[4] Hokkaido Univ, Sch Med, Dept Publ Hlth, Sapporo, Hokkaido 060, Japan
[5] Jikei Univ, Sch Med, Aoto Hosp, Dept Med, Tokyo, Japan
来源
关键词
D O I
10.1067/mlc.2000.105617
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Angiotensin-converting enzyme inhibitors (ACEIs) cause regression of hypertensive left ventricular hypertrophy (LVH) by reducing angiotensin II, increasing bradykinin, or both. The mechanisms of these cardioprotective effects remain controversial. The aims of this study were to determine whether the cardioprotective effects of ACEIs are mediated by reducing angiotensin II and whether ACEIs ameliorate the morphologic, physiologic, and biochemical changes in the hearts of stroke-prone spontaneously hypertensive rats (SHRSPs). Male SHRSPs were treated with hydralazine, captopril, or candesartan, an angiotensin II type 1 receptor(AT1R) antagonist, from age 12 to 24 weeks. We measured systolic blood pressure (SBP), left ventricular weight (LVW), left ventricular (LV) myocyte cross-sectional area (myocyte size), LV interstitial collagen volume fraction (ICVF), perivascular collagen area/luminal area ratio (PVCA/LA), the medial area to luminal area ratio (MA/LA), the relative amount of V3 myosin heavy chain (MHCV3), and coronary reserve maximum (coronary flow max/ventricular weight (CFmax/VW)). These parameters were compared with those of untreated SHRSPs and Wistar-Kyoto mts (WKYs). SHRSPs exhibited decreased coronary reserve and LVH with an increase in myocyte size, PVCA/LA, MA/LA, and MHCV3 at 12 weeks of age. In addition to these changes, 24-week-old SHRSPs showed an increase in ICVF. The LVW coronary reserve, myocyte size, PVCA/LA, ICVF, and MHCV3 of SHRSPs treated with captopril or candesartan all approached control values. In contrast, hydralazine decreased only ICVF. These results suggest that ACEIs regress LVH and normalize coronary reserve by modulating the effects of angiotensin II via AT1R on the induction of cardiomyocyte hypertrophy, perivascular fibrosis, and medial thickening of intramyocardial coronary arteries in SHRSPs. We concluded that these effects, in addition to the reduction of SEP, are important in causing the regression of LVH.
引用
收藏
页码:353 / 359
页数:7
相关论文
共 50 条
  • [41] HYPERTENSIVE ARTERIOLAR ANEURYSMS IN THE RETINAE OF STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS
    HAMADA, Y
    HAMADA, M
    YONEMOTO, H
    UYAMA, R
    NAKAO, Y
    OTORI, T
    MIYAKE, H
    SUZUKI, T
    OKAMOTO, K
    JAPANESE HEART JOURNAL, 1983, 24 (05): : 815 - 815
  • [42] Cardiac hypertrophy in diabetic spontaneously hypertensive rats: Role of angiotensin II?
    Black, MJ
    Briscoe, T
    Bertram, JF
    Jackson, B
    Johnston, CI
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1997, 24 (06) : 445 - 448
  • [43] IMPAIRED INSULIN METABOLISM IN STROKE-RESISTANT SPONTANEOUSLY HYPERTENSIVE RATS AND STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS
    SATO, T
    NARA, Y
    KATO, Y
    YAMORI, Y
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 1994, 4 (03) : 155 - 158
  • [44] A STUDY OF THE RELATIONSHIP BETWEEN ARTERIAL AND INTRACRANIAL HYPERTENSION IN THE M-STRAIN OF STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS AND STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS
    OHTA, Y
    CHIKUGO, T
    HIGASHIZAWA, T
    CHICHIBU, S
    OKAMOTO, K
    JOURNAL OF HYPERTENSION, 1986, 4 : S409 - S411
  • [45] Heart-bound adiponectin, not serum adiponectin, inversely correlates with cardiac hypertrophy in stroke-prone spontaneously hypertensive rats
    Inoue, Takao
    Takemori, Kumiko
    Mizuguchi, Nobuyuki
    Kimura, Masatomo
    Chikugo, Takaaki
    Hagiyama, Man
    Yoneshige, Azusa
    Mori, Tatsufumi
    Maenishi, Osamu
    Kometani, Takashi
    Itoh, Tatsuki
    Satou, Takao
    Ito, Akihiko
    EXPERIMENTAL PHYSIOLOGY, 2017, 102 (11) : 1435 - 1447
  • [46] MECHANISMS OF PROTECTION AGAINST STROKE IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS
    SADOSHIMA, S
    BUSIJA, DW
    HEISTAD, DD
    AMERICAN JOURNAL OF PHYSIOLOGY, 1983, 244 (03): : H406 - H412
  • [47] Celastrol attenuates angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis by inhibiting STAT3
    Ye, Shiju
    Huang, Weijian
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : C39 - C39
  • [49] PROPHYLACTIC EFFECT OF IMIDAPRIL ON STROKE IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS
    OGIKU, N
    SUMIKAWA, H
    HASHIMOTO, Y
    ISHIDA, R
    STROKE, 1993, 24 (02) : 245 - 252
  • [50] Prevention of stroke with perindopril treatment in stroke-prone spontaneously hypertensive rats
    Wang, H
    Delaney, KH
    Kwiecien, JM
    Smeda, JS
    Lee, RMKW
    CLINICAL AND INVESTIGATIVE MEDICINE, 1997, 20 (05): : 327 - 338